5.20
                                            Solid Biosciences Inc Stock (SLDB) Forecast
The Solid Biosciences Inc (SLDB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $38.33, representing a +637.18% increase from the current price of $5.20. The highest analyst price target is $37.72, and the lowest is $38.95.
                Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
        12-Month SLDB Price Target
            
                Average 44.16 
                (+749.24% Upside)
                
                    
                        
                    
                
            
        Is Solid Biosciences Inc (SLDB) A Buy Now?
Oscillators
                | Name | Value | Action | 
|---|---|---|
| RSI(14) | 40.23 | Neutral | 
| STOCH(9,6) | 19.30 | Buy | 
| STOCHRSI(14) | 9.9133 | Buy | 
| MACD(12,26) | -0.1154 | Sell | 
| ADX(14) | 13.00 | Neutral | 
| William %R | -92.45 | Buy | 
| CCI(14) | -133.77 | Sell | 
                            Buy: 3
                            Sell: 2
                            Neutral: 2
                        
                        Summary: Buy
                        Moving Averages
                | Period | Simple | Exponential | 
|---|---|---|
| MA10 | 
                                     5.60 
                                        Sell 
                                     | 
                                
                                     5.569 
                                        Sell 
                                     | 
                            
| MA20 | 
                                     5.847 
                                        Sell 
                                     | 
                                
                                     5.6983 
                                        Sell 
                                     | 
                            
| MA50 | 
                                     5.683 
                                        Sell 
                                     | 
                                
                                     5.7208 
                                        Sell 
                                     | 
                            
| MA100 | 
                                     5.7083 
                                        Sell 
                                     | 
                                
                                     5.5137 
                                        Sell 
                                     | 
                            
| MA200 | 
                                     4.7683 
                                        Buy 
                                     | 
                                
                                     5.4667 
                                        Sell 
                                     | 
                            
                            Buy: 1
                            Sell: 9
                            Neutral: 0
                        
                        Summary: Sell
                        
                According to our latest analysis, SLDB could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SLDB, as trading bearish markets can be challenging and may result in losses.
            
            - RSI (Relative Strength Index): The RSI(14) value of 40.23 indicates that SLDB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
 - STOCH (Stochastic Oscillator): The STOCH value of 19.3 indicates that SLDB is oversold. This indicates that SLDB price is at or near the lowest level over a specified lookback period.
 - STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.9133 indicates that SLDB is oversold. This suggests that SLDB price is at or near the lowest level relative to its recent price history.
 - ADX (Average Directional Index): The ADX value of The ADX value of 13 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
 - CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -133.77 indicates that SLDB is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
 
Long-term SLDB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Solid Biosciences Inc financial reports and earnings history, Solid Biosciences Inc (SLDB) stock could reach $173.25 by 2030, $101.69 by 2040 and $299.78 by 2050. See the projected annual prices until 2050 of the Solid Biosciences Inc stock below:
- Solid Biosciences Inc (SLDB) is expected to reach an average price of $37.94 in 2035, with a high prediction of $41.67 and a low estimate of $38.40. This indicates an $629.56% rise from the last recorded price of $5.20.
 - Solid Biosciences Inc (SLDB) stock is projected to chart a bullish course in 2040, with an average price target of $97.99, representing an $1,784% surge from its current level. The forecast ranges from a conservative $98.44 to a sky-high $101.69.
 - Our analysts predict Solid Biosciences Inc (SLDB) to jump 3,440% by 2045, soaring from $184.50 to an average price of $184.06, potentially reaching $186.07. While $184.50 is the low estimate, the potential upside is significant.
 - Solid Biosciences Inc (SLDB) stock is expected to climb by 2050, reaching an average of $285.38, a $5,388% jump from its current level. However, a wide range of estimates exists, with high and low targets of $299.78 and $292.43, respectively, highlighting the market's uncertainty.
 
Solid Biosciences Inc Stock (SLDB) Year by Year Forecast
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2025
                                Solid Biosciences Inc Stock (SLDB) is expected to reach an average price of $55.35 in 2025, with a high prediction of $71.75 and a low estimate of $38.95. This indicates an +964.42% rise from the last recorded price of $5.20.
                            
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| December, 2025 | $45.07 | $38.95 | $37.72 | +766.71% | 
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2026
                            The predicted value for Solid Biosciences Inc (SLDB) in 2026 is set at an average of $44.16. Estimates vary from a peak of $86.96 to a trough of $1.3636, indicating an +749.24% surge from the present price of $5.20.
                        
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| January, 2026 | $44.78 | $46.53 | $43.20 | +761.15% | 
| February, 2026 | $19.41 | $20.34 | $42.42 | +273.26% | 
| March, 2026 | $7.9984 | $4.6984 | $38.71 | +53.82% | 
| April, 2026 | $18.00 | $1.6418 | $42.49 | +246.10% | 
| May, 2026 | $1.7864 | $1.3636 | $86.96 | -65.65% | 
| June, 2026 | $5.7245 | $3.1342 | $8.6462 | +10.09% | 
| July, 2026 | $29.48 | $7.1951 | $9.9756 | +466.84% | 
| August, 2026 | $18.54 | $25.06 | $22.55 | +256.47% | 
| September, 2026 | $27.44 | $22.03 | $23.39 | +427.64% | 
| October, 2026 | $34.65 | $33.63 | $33.30 | +566.32% | 
| November, 2026 | $34.21 | $34.66 | $35.48 | +557.87% | 
| December, 2026 | $36.81 | $33.61 | $32.16 | +607.89% | 
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2027
                                For 2027, Stockscan's Analyst expects the average price target for Solid Biosciences Inc (SLDB) is $43.48, with a high forecast of $49.52 and a low forecast of $37.45. This indicates an +736.22% increase from the last price of $5.20.
                            
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| January, 2027 | $40.57 | $37.45 | $37.35 | +680.22% | 
| February, 2027 | $39.68 | $38.74 | $38.66 | +663.12% | 
| March, 2027 | $37.93 | $41.52 | $40.40 | +629.49% | 
| April, 2027 | $44.84 | $38.87 | $38.84 | +762.39% | 
| May, 2027 | $47.11 | $46.23 | $45.71 | +805.87% | 
| June, 2027 | $50.86 | $47.52 | $49.52 | +878.01% | 
| July, 2027 | $42.52 | $42.18 | $44.80 | +717.63% | 
| August, 2027 | $46.69 | $42.41 | $43.13 | +797.98% | 
| September, 2027 | $47.99 | $49.63 | $49.06 | +822.82% | 
| October, 2027 | $46.52 | $46.79 | $47.42 | +794.70% | 
| November, 2027 | $43.70 | $44.78 | $44.74 | +740.42% | 
| December, 2027 | $39.50 | $40.85 | $42.64 | +659.62% | 
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2028
                                In 2028, Solid Biosciences Inc (SLDB) is projected to reach an average price of $32.49, with a high projection of $39.96 and a low estimate of $25.01. This indicates an +524.73% rise from the last price of $5.20.
                            
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| January, 2028 | $40.14 | $40.20 | $39.96 | +671.98% | 
| February, 2028 | $41.22 | $40.74 | $39.37 | +692.78% | 
| March, 2028 | $39.76 | $40.25 | $39.94 | +664.71% | 
| April, 2028 | $37.87 | $38.04 | $39.31 | +628.18% | 
| May, 2028 | $36.85 | $36.59 | $37.26 | +608.59% | 
| June, 2028 | $33.52 | $34.10 | $36.27 | +544.57% | 
| July, 2028 | $32.25 | $32.11 | $32.59 | +520.16% | 
| August, 2028 | $32.25 | $32.28 | $31.90 | +520.18% | 
| September, 2028 | $30.74 | $31.02 | $32.15 | +491.16% | 
| October, 2028 | $28.53 | $29.13 | $29.63 | +448.68% | 
| November, 2028 | $25.54 | $25.68 | $26.97 | +391.20% | 
| December, 2028 | $24.95 | $25.01 | $24.97 | +379.87% | 
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2029
                                The 2029 price forecast for Solid Biosciences Inc Stock (SLDB) is $52.97 on average, with a high prediction of $105.72 and a low estimate of $0.2266. This represents an +918.72% increase from the previous price of $5.20.
                            
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| January, 2029 | $23.83 | $23.87 | $24.35 | +358.35% | 
| February, 2029 | $22.76 | $22.86 | $23.47 | +337.60% | 
| March, 2029 | $21.75 | $21.87 | $22.32 | +318.20% | 
| April, 2029 | $21.07 | $21.13 | $21.24 | +305.14% | 
| May, 2029 | $18.97 | $19.13 | $20.33 | +264.77% | 
| June, 2029 | $16.53 | $16.72 | $17.71 | +217.87% | 
| July, 2029 | $11.76 | $12.49 | $13.48 | +126.15% | 
| August, 2029 | $8.961 | $9.0008 | $11.01 | +72.33% | 
| September, 2029 | $4.2019 | $5.0819 | $8.2312 | -19.19% | 
| October, 2029 | $1.587 | $0.5119 | $3.5021 | -69.48% | 
| November, 2029 | $1.8239 | $0.2266 | $3.2968 | -64.93% | 
| December, 2029 | $119.82 | $0.4845 | $105.72 | +2,204% | 
Solid Biosciences Inc Stock (SLDB) Price Forecast for 2030
                                Solid Biosciences Inc Stock (SLDB) is expected to reach an average price of $120.63 in 2030, with a high forecast of $179.80 and a low forecast of $61.46. This signifies an +2,220% surge from the last price of $5.20.
                            
                    | Month | Average | Low | High | Change from today's price | 
|---|---|---|---|---|
| January, 2030 | $178.72 | $176.08 | $173.25 | +3,337% | 
| February, 2030 | $170.94 | $175.51 | $173.40 | +3,187% | 
| March, 2030 | $158.37 | $167.67 | $168.92 | +2,945% | 
| April, 2030 | $122.24 | $118.86 | $144.21 | +2,251% | 
| May, 2030 | $87.39 | $87.91 | $91.57 | +1,581% | 
| June, 2030 | $56.96 | $61.46 | $77.87 | +995.41% | 
| July, 2030 | $169.26 | $71.48 | $167.46 | +3,155% | 
| August, 2030 | $167.86 | $169.95 | $165.44 | +3,128% | 
| September, 2030 | $173.43 | $165.03 | $160.30 | +3,235% | 
| October, 2030 | $175.26 | $172.02 | $173.31 | +3,270% | 
| November, 2030 | $165.68 | $175.65 | $172.42 | +3,086% | 
| December, 2030 | $184.75 | $182.41 | $179.80 | +3,453% | 
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):